American Oncology Network announced that Dave Gould will step down as Chief Financial Officer, effective May 17, 2024, to pursue other opportunities. The company has appointed David Afshar, a seasoned public company executive, to fulfill the responsibilities of interim Chief Financial Officer, effective May 20, 2024. The company has initiated a process for a new Chief Financial Officer.

Afshar is an experienced Chief Financial Officer with strong financial, operations and administrative experience in high-performing environments. He has over 25 years of experience in healthcare services, beginning in public accounting and progressing to Chief Financial Officer. Afshar is seasoned in both private equity-backed and public company environments and has a thorough understanding of key stakeholder needs, including public and private equity shareholders, physician shareholders, lenders and rating agencies.

He has served as the Chief Financial Officer at companies from $300 million in revenue to over $1.8 billion. This includes companies with operations in over 300 locations across the country in pediatric and adult home healthcare, long-term acute care, and multi-specialty physician practices.